Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

market news

< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
99 100 Next >
Tesla Stock Falls Over 5% During Pre-Market After Elon Musk-Led EV Giant Recalls Nearly 700,000 Vehicles
Via Benzinga
Topics Product Recall
Exposures Legal Product Safety
Tickers TSLA
Top 3 Tech Stocks That Could Blast Off In Q4
Via Benzinga
Tickers ACLS AMAT MCHP
USD/JPY Dips To Test A Previous Top At 156.60 Following Hot Japanese Inflation
Via Talk Markets
Topics Currencies/Forex Economy
Exposures Interest Rates
Tickers FXY UUP
Could This AI Stock Be the Next Nvidia?
Via The Motley Fool
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tickers AVGO NVDA
Is ASML Stock a Buy?
Via The Motley Fool
Tickers ASML
Investors should take note of NASDAQ:CORT, a growth stock that remains attractively priced.
Via Chartmill
Tickers CORT
Why NASDAQ:CME qualifies as a quality stock.
Via Chartmill
Tickers CME
Could AMD Soar in 2025?
Via The Motley Fool
Tickers AMD
Why Oatly Stock Was Sinking This Week
Via The Motley Fool
Tickers OTLY
FDA Approves Ionis Pharmaceuticals' Rare Genetic Disease Therapy to Lower High-Level Of Fat In Blood
Via Benzinga
Exposures Product Safety
Tickers IONS
Winnebago (NYSE:WGO) Misses Q4 Revenue Estimates
Via StockStory
Tickers WGO
Broadcom Expects Decade-Long AI Chip Boom as Big Tech Invest Billions
Via Benzinga
Topics Artificial Intelligence
Exposures Artificial Intelligence
Tickers AAPL AMD AVGO GOOG
2 No-Brainer Warren Buffett Investments to Buy Right Now
Via The Motley Fool
Tickers AXP VOO
Analyzing NYSE:TTC's Dividend Potential.
Via Chartmill
Tickers TTC
Breaking Down Evercore: 5 Analysts Share Their Views
Via Benzinga
Tickers EVR
What 8 Analyst Ratings Have To Say About Avidity Biosciences
Via Benzinga
Tickers RNA
A Glimpse Into The Expert Outlook On Dollar Tree Through 16 Analysts
Via Benzinga
Tickers DLTR
Polish Consumers Show Renewed Enthusiasm In November
Via Talk Markets
Tickers EPOL
Novo Nordisk Dives On CagriSegma Obesity Drug Trial. Eli Lilly, Viking Jump.
Via Investor's Business Daily
Tickers AMGN LLY MRK NVO
Why Investors Were Ice-Cold on Celsius Holdings This Week
Via The Motley Fool
Tickers CELH
Merck & Co Inc (MRK) DCF Valuation: Is The Stock Undervalued?
Via Talk Markets
Topics Stocks / Equities
Tickers MRK
Deep Dive Into Tradeweb Markets Stock: Analyst Perspectives (12 Ratings)
Via Benzinga
Tickers TW
Have Risk Appetite? Here Are 5 Cryptos That Could Make Your Christmas Merry
Via Benzinga
Tickers ENA
What 4 Analyst Ratings Have To Say About Spero Therapeutics
Via Benzinga
Tickers SPRO
Is Wall Street Really Buying 44% Of Homes? Report Says Not Even Close
Via Benzinga
Forecasting The Future: 14 Analyst Projections For Rhythm Pharmaceuticals
Via Benzinga
Tickers RYTM
Strategic Planning Need Not Be A Dreaded Annual Chore
Via Investor's Business Daily
Tickers GNRC
Riksbank And Banxico Cut Interest Rates By 0.25%
Via Talk Markets
Topics Commodities Stocks / Equities
Tickers OIL SPX UNG
When you look at NASDAQ:PPC, it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.
Via Chartmill
Tickers PPC
Novo Nordisk's Hybrid Weight Loss Drug Falls Short On Expectations, Stock Plunges
Via Benzinga
Tickers LLY NVO
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.